Search Results for "Muse"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Muse. Results 1 to 1 of 1 total matches.
See also: alprostadil

Anifrolumab (Saphnelo) for Systemic Lupus Erythematosus

   
The Medical Letter on Drugs and Therapeutics • Sep 20, 2021  (Issue 1633)
of anifrolumab was based on the results of three 52-week, double-blind trials (MUSE, TULIP-1, and TULIP-2 ...
The FDA has approved anifrolumab-fnia (Saphnelo – AstraZeneca), a type I interferon receptor antagonist, for IV treatment of adults with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard treatment. Anifrolumab has not been studied in patients with severe active lupus nephritis or severe active CNS lupus. It is the first type I interferon receptor antagonist to become available in the US.
Med Lett Drugs Ther. 2021 Sep 20;63(1633):146-7 |  Show IntroductionHide Introduction